Literature DB >> 22366656

Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production.

Tuan-Ahn N Pham1, Haiyan Che, Phuong-Thuy T Phan, Jae-Won Lee, Sung-Soo Kim, Haeil Park.   

Abstract

A number of oroxylin A analogs were prepared and evaluated for their inhibitory activities against iNOS-mediated nitric oxide (NO) production from LPS-stimulated BV2 cells. The analogs were synthesized from purchased 2'-hydroxy-4,5,6-trimethoxyacetophenone and aldehydes in 3 steps. Among the tested compounds, several analogs (3b, 3c, 3d, 3f) exhibited strong inhibitory activities. Especially, the analog with 4-nitrophenyl group (3b) showed stronger inhibitory activity (IC(50)=4.73 μM) than that of wogonin (IC(50)=7.80 μM).
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366656     DOI: 10.1016/j.bmcl.2012.01.135

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774.1.

Authors:  Naohiro Oshima; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2012-06-23       Impact factor: 2.343

Review 2.  Agarwood-The Fragrant Molecules of a Wounded Tree.

Authors:  Pooja Shivanand; Nurul Fadhila Arbie; Sarayu Krishnamoorthy; Norhayati Ahmad
Journal:  Molecules       Date:  2022-05-24       Impact factor: 4.927

3.  STAT1 mediates oroxylin a inhibition of iNOS and pro-inflammatory cytokines expression in microglial BV-2 cells.

Authors:  Po-Wen Liu; Mei-Fang Chen; Andy Po-Yi Tsai; Tony J F Lee
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

4.  Oroxylin A promotes retinal ganglion cell survival in a rat optic nerve crush model.

Authors:  Shu-Fang Lin; Jia-Ying Chien; Kishan Kapupara; Chi-Ying F Huang; Shun-Ping Huang
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.